General Information of the Compound
Compound ID
CP0057055
Compound Name
(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid
    Show/Hide
Synonyms
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
3,7,12-Trihydroxycholanic acid
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid
81-25-4
BHQCQFFYRZLCQQ-OELDTZBJSA-N
CHEBI:16359
CHEMBL205596
Cholalic acid
Cholalin
Cholic Acid
Cholic acid [USAN]
Cholic acid, 5beta-
Cholsaeure
Colalin
G1JO7801AE
HSDB 982
NSC-6135
NSC6135
UNII-G1JO7801AE
cholate
cholic acid
    Show/Hide
Structure
Formula
C24H40O5
Molecular Weight
408.579
Canonical SMILES
C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
    Show/Hide
InChI
InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1
    Show/Hide
InChIKey
BHQCQFFYRZLCQQ-OELDTZBJSA-N
CAS
81-25-4
Physicochemical Property
logP
3.4487
Rotatable Bonds
4
Heavy Atom Count
29
Polar Areas
97.99
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 221493
SID: 123055413
ChEMBL ID
CHEMBL205596
DrugBank ID
DB02659
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000109 COS-1 Chlorocebus aethiops (Green monkey)  1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 45000 nM
Protein ID: PT02509, G-protein coupled bile acid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
EC50 = 13600 nM
   TI
   LI
   LO
   TS
CL000126 NCI-H716 Homo sapiens (Human)  1
1
EC50 = 13600 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 6000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 19830 nM
Protein ID: PT04975, G-protein coupled bile acid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Cholic Acid )
Drug Name Cholic Acid
Indication
Synthesis disorder
Approved
Peroxisomal disorder
Approved
Target(s)
Phospholipase A2 (PLA2G1B)
Inhibitor
Ferrochelatase (FECH)
Inhibitor
Liver carboxylesterase (CES1)
Inhibitor